National program highlights innovative, minimally invasive, non-opioid treatment option for chronic pain patients
OCALA, Fla. — Sept. 10, 2019 — Stimwave Technologies, the leading innovator of wireless medical pain relief implant bioelectric technology, announced today that it named The Pain Treatment Center of Ocala, founded by Dr. Stephen Pyles, a Stimwave Center of Excellence as part of its recently launched national program to spotlight physicians that provide unparalleled commitment and dedication to patient outcomes.
The Stimwave Centers of Excellence program recognizes facilities that are dedicated to creating an inclusive and evidence-driven environment for chronic pain patients, and have demonstrated a high degree of clinical competence in helping appropriate patients utilize Stimwave’s unique and advanced micro-technology.
More than 400 million people worldwide endure daily chronic pain. The Stimwave Stimulator System provides a non-surgical therapy option for chronic pain with just a single device implanted through a needle.
“I’m thrilled to be a part of this important initiative to help advance standards of care for patients suffering from chronic pain,” commented Dr. Stephen Pyles. “Stimwave’s Wireless Pain Relief® technology is revolutionizing the industry with its easily wearable options giving patients and clinicians affordable choices for pain management.”
“The Centers of Excellence program is committed to continually raising the bar for treatment solutions for chronic pain sufferers. We’re excited to have Dr. Pyles participate in this important initiative and look forward to gaining valuable insights based on his deep expertise in the space and daily work with patients,” said Dr. Andrea M. Trescot, Chief Medical Officer of Stimwave.
Stimwave offers the world’s only wireless, battery-free, opioid-free implant cleared by the FDA to treat chronic neuropathic pain throughout the body, from back and leg pain addressed by spinal cord stimulation (SCS) to peripheral nerve stimulation (PNS) that treats pain at the source, including shoulder pain, wrist pain, elbow pain, knee pain, hip pain and more. This approach allows more patients to be treated than ever before with a viable, affordable alternative to help fight opioid usage across the country.
Representing a life-changing technological breakthrough for the more than 400 million people worldwide who endure daily chronic pain, the Stimwave Freedom Stimulators are also the smallest neuromodulation devices available, at a volume size of 0.4 cc compared to the next smallest form factor at 15 cc and greater – Stimwave’s implants are 35x-100x smaller than any conventional system.
As a Stimwave Center of Excellence, Dr. Pyles will give back to the greater Stimwave community through voluntary engagement in a committee to provide critical, ongoing feedback and insights in the areas of clinical, product, procedural, reimbursement and education.
About The Pain Treatment Center of Ocala
Dr. Pyles started The Pain Treatment Center of Ocala in 1985 with the goal of providing a location for physicians and their patients to receive quality efficient diagnosis and treatment of chronic pain conditions. Most all chronic pain syndromes are treated at The Pain Treatment Center of Ocala; however, the practice is primarily an "interventional" type of pain management program with an emphasis on using neuromodulation techniques such as peripheral nerve stimulation and spinal cord stimulation. Dr. Pyles has both a national and an international reputation as an innovator in the field of neuromodulation. For more information visit www.paintreatmentcenters.net.
Stimwave Technologies Incorporated is a privately held medical device company engaged in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic burden of pain management. www.stimwave.com.